However, most of the current treatment options in type 2 diabetes and prediabetes target mainly the symptoms rather than insulin sensitivity and adipose tissue metabolism as causative factors (Soccio et al, 2014; Chatterjee et al, 2017). Here, INS is linked to type 2 diabetes mellitus.